{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:49:25Z","timestamp":1794862165590,"version":"4.9.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Studying antibody dynamics following re-exposure to infection and\/or vaccination is crucial for a better understanding of fundamental immunological processes, vaccine development, and health policy research.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We adopted a nonlinear mixed modeling approach based on ordinary differential equations (ODE) to characterize varicella-zoster virus specific antibody dynamics during and after clinical herpes zoster. Our ODEs models convert underlying immunological processes into mathematical formulations, allowing for testable data analysis. In order to cope with inter- and intra-individual variability, mixed models include population-averaged parameters (fixed effects) and individual-specific parameters (random effects). We explored the use of various ODE-based nonlinear mixed models to describe longitudinally collected markers of immunological response in 61 herpes zoster patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Starting from a general formulation of such models, we study different plausible processes underlying observed antibody titer concentrations over time, including various individual-specific parameters. Among the converged models, the best fitting and most parsimonious model implies that once Varicella-zoster virus (VZV) reactivation is clinically apparent (i.e., Herpes-zoster (HZ) can be diagnosed), short-living and long-living antibody secreting cells (SASC and LASC, respectively) will not expand anymore. Additionally, we investigated the relationship between age and viral load on SASC using a covariate model to gain a deeper understanding of the population\u2019s characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results of this study provide crucial and unique insights that can aid in improving our understanding of VZV antibody dynamics and in making more accurate projections regarding the potential impact of vaccines.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1104605","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T12:23:00Z","timestamp":1676550180000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Modeling antibody dynamics following herpes zoster indicates that higher varicella-zoster virus viremia generates more VZV-specific antibodies"],"prefix":"10.3389","volume":"14","author":[{"given":"Hajar","family":"Besbassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Garcia-Fogeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Quinlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niel","family":"Hens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Ogunjimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Beutels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/148.2.200","article-title":"Immunologic evidence of reinfection with varicella-zoster virus","volume":"148","author":"Arvin","year":"1983","journal-title":"J Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2010.0031","article-title":"Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents","volume":"24","author":"Ogunjimi","year":"2011","journal-title":"Viral Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1086\/421277","article-title":"Development of virus- specific CD4 + T cells on reexposure to varicella zoster virus","volume":"190","author":"Vossen","year":"2004","journal-title":"J Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pcbi.1002418","article-title":"Living on three time scales: The dynamics of plasma cell and antibody populations illustrated for hepatitis a virus","volume":"8","author":"Andraud","year":"2012","journal-title":"PloS Comput Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00912.x","article-title":"Mechanisms that determine plasma cell lifespan and the duration of humoral immunity","volume":"236","author":"Amanna","year":"2010","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"04","DOI":"10.1016\/j.vaccine.2019.03.075","article-title":"An ODE-based mixed modelling approach for b- and T-cell dynamics induced by varicella-zoster virus vaccines in adults shows higher T-cell proliferation with shingrix than with varilrix","volume":"37","author":"Keersmaekers","year":"2019","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s11538-018-0465-8","article-title":"Controlling il-7 injections in hiv-infected patients","volume":"80","author":"Pasin","year":"2018","journal-title":"Bull Math Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169164","article-title":"Integrative analysis of immunological data to explore chronic immune t-cell activation in successfully treated hiv patients","volume":"12","author":"Picat","year":"2017","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2010.10.014","article-title":"Persistence of varicella-zoster virus viraemia in patients with herpes zoster","volume":"50","author":"Quinlivan","year":"2011","journal-title":"J Clin Virol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00721","article-title":"The maintenance of memory plasma cells","volume":"10","author":"Khodadadi","year":"2019","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2017.04.014","article-title":"Protective and pathogenic memory plasma cells","volume":"189","author":"Hoyer","year":"2017","journal-title":"Immunol Lett"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300161","article-title":"What is and what should always have been: long-lived plasma cells induced by t cell-independent antigens","volume":"190","author":"Bortnick","year":"2013","journal-title":"J Immunol (Baltimore Md.: 1950)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B15","volume-title":"[Dataset] version 2021R1","year":"2021"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.csda.2004.07.002","article-title":"Maximum likelihood estimation in nonlinear mixed effects models","volume":"49","author":"Kuhn","year":"2005","journal-title":"Comput Stat Data Anal"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Automat. Control"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12612","article-title":"A novel method based on unbiased correlations tests for covariate selection in nonlinear mixed effects models: The COSSAC approach","volume":"10","author":"Ayral","year":"2021","journal-title":"CPT: Pharmacometrics Syst Pharmacol"},{"key":"B19","first-page":"3","article-title":"Clinical utility of hiv-1 viral load in resource-limited settings","volume":"35","author":"Ko","year":"2020","journal-title":"Korean J Internal Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00054","article-title":"The role of aging on immune responses to infections and vaccines","volume":"35","author":"Chen","year":"2020","journal-title":"Front Immunol"},{"key":"B21","article-title":"The aging immune system: a comprehensive review","volume":"62","author":"Vaidya","year":"2017","journal-title":"Indian J Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01146-16","article-title":"Gp350-specific neutralizing activity is correlated with peripheral blood epstein-barr virus dna levels during acute infectious mononucleosis","volume":"63","author":"Weiss","year":"1989","journal-title":"J Virol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nri1886","article-title":"Competence and competition: The challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00938.x","article-title":"Memory b and memory plasma cells","volume":"237","author":"Yoshida","year":"2010","journal-title":"Nat Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1104605\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T12:23:07Z","timestamp":1676550187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1104605\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2023.1104605"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1104605","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2023.1104605.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2023.1104605.s002","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"article-number":"1104605"}}